Several different anti-cancer and GBM treatment approaches based on MIF inhibition have been proposed and include competitive, irreversible and endogenous inhibitors, molecules that destabilize MIF, and monoclonal antibodies blocking MIF or CD74 [34, 103, 142]. The gene discussed is CD74; the disease is glioblastoma.